Separate names with a comma.
MindMed’s Bet on Psychedelic Psychiatry: Vanguards of Health Care...
MNMD - SCHEDULE 14A INFORMATION - Proxy Statement Notes...
MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)...
I am not a fan of what is going on. No one is really. However, there are some silver linings here. Despite concerns around potential...
Trump Stalls Cannabis Reform, Plus Mindmed CEO's 2025 Outlook | Trade to BLack - Dale's Report https://www.youtube.com/live/Vn6tQineSwM
Trump’s Veterans Secretary Had ‘Eye-Opening’ Psychedelics Talk With RFK Jr.—And He Plans To Press Congress To Act...
NPR - Why tech bros worship psychedelics (and think you should too) March 24, 20253:00 AM ET...
MindMed Appoints Matt Wiley as Chief Commercial Officer...
U.S. Government Accountability Office - Science & Tech Spotlight: Medical Use of Psychedelics https://www.gao.gov/products/gao-25-108021
Congressional Psychedelics Advancing Therapies (PATH) Caucus - Full PDF from Association for Prescription Psychedelics Inc....
March 2025 - Corporate Presentation...
MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates...
Oprah - Can Psychedelics Heal Mental Trauma? With Harvard Professor Michael Pollan [MEDIA]
Not sure why the strike through happened. Copy and pasted. Lot's of links to research.
MindMed MM-120 (LSD) in GAD: Recent Research, Regulatory Developments, and Market Impact Recent LSD Research in Mental Health and GAD Growing...
Subject: atai: I have increased my stake from 19.9% to 22.3% by investing 22.75m USD Dear Friends! I am very happy to announce that within the...
Price Target 8-10
Psilera Inc. & atai Life Sciences Announce Licensing Agreement for DMT Patent Portfolio...
Apeiron Investment Group purchases $22.8m in ATAI Life Sciences shares...
Nasdaq is 1.00 minimum. So they may have to RS to get there, but this is a 5-10x play here just on the hype of the uplist. Should be interesting!
